Want to join the conversation?
$BLL estimates cash flows from operating activities including cash transaction costs for the proposed acquisition of Rexam, for 2016 to be in the range of $900MM, Capex to be about $400MM and free cash flow to be in the range of $500MM. Of the total 2016 estimated Capex, approx. $150MM was contractually committed as of December 31, 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?